[Effectiveness of recombinant activated factor VIIA (NovoSeven) in case of severe obstetric complication with coagulopathy].

The aim of report is to present the possibilities of applying NovoSeven in serious coagulopathy in course of various obstetrical complications. At present it is utilised in acquired coagulopathy, bleedings, traumatic cases and extensive surgical operations especially associated with DIC. We report two cases of severe complications during delivery.